Mount Sinai
The Mount Sinai Health System is an integrated health care system providing exceptional medical care to local and global communities. Encompassing the Icahn School of Medicine at Mount Sinai and eight hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint, Mount Sinai is internationally acclaimed for its excellence in research, patient care, and education across a range of specialties.
They have specialists in hematology, oncology, myeloma, amyloidosis, blood disorders, and other areas. The health care providers at Mount Sinai will examine you for amyloidosis and other associated problems. You will be asked about your medical history and symptoms. A physical exam may show that you have a swollen liver or spleen, or signs of nerve damage. Treatment will be provided based on the results of the exams and tests.
Mount Sinai has cancer treatment locations throughout the New York metropolitan area. The doctors work with specialized centers and participate in programs with cancer experts.
In addition, through clinical trials for amyloidosis, the institute is able to offer you new treatment options for cancer and amyloidosis. NCT03336580 is one such trial that is studying PRX004 in subjects with amyloid transthyretin (ATTR) amyloidosis.
The team includes healthcare professionals in the following areas:
